Previous 10 | Next 10 |
Company Expands North America Commercial Capabilities ENGLEWOOD, CO / ACCESSWIRE / August 22, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today announced an exclusive distribution agreement with Salient Medical ...
Nanocap Viveve Medical (NASDAQ: VIVE ) has fallen 23.6% after hours after filing to offer up to $6.8M in shares , more than the closing market cap of the company. More news on: Viveve Medical, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Viveve Medical, Inc. (VIVE) Q2 2019 Earnings Conference Call August 8, 2019 4:30 PM ET Company Participants Scott Durbin – Chief Executive Officer and Director Jeannie Swindle – Senior Director-Corporate Communications Conference Call Participants Josh Jennings ...
Viveve Medical (NASDAQ: VIVE ): Q2 GAAP EPS of -$0.21 misses by $0.03 . More news on: Viveve Medical, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
Company completed successful transition from capital sales to recurring revenue model Achieved U.S. FDA 510k and CE Mark clearances for Viveve 2.0 Expanded international distribution partnership in Middle East Company to host conference call at 4:30 pm ET today ...
ENGLEWOOD, CO / ACCESSWIRE / August 7, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today reported additional clinical results from the LIBERATE-International Trial, a multicentered, randomized, double-blind...
ENGLEWOOD, CO / ACCESSWIRE / August 1, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today announced that it will report its second quarter 2019 financial results after the close of the U.S. financial markets on Thursday...
Karuna Therapeutics (NASDAQ: KRTX ) initiated with Buy rating and $28 (42% upside) price target at Citigroup. Initiated with Buy rating and $34 price target at Goldman Sachs. Initiated with Outperform rating and $38 price target at Wedbush. Initiated with Outperform rating and $29 price targ...
Nano cap Viveve Medical (NASDAQ: VIVE ) craters 64% premarket on robust volume in reaction to unsuccessful results from the LIBERATE-International study evaluating its cryogen-cooled monopolar radiofrequency (CMRF) technology for the improvement of stress urinary incontinence (...
ENGLEWOOD, CO / ACCESSWIRE / July 22, 2019 / Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women’s intimate health, today provided an update on the company’s clinical development programs and transition to a new U.S. business model, and also a...
News, Short Squeeze, Breakout and More Instantly...
Novonix Limited (NVNXF) is expected to report for quarter end 2023-12-31 MedAvail Holdings Inc. (MDVL) is expected to report for Q3 2023 Nobility Homes, Inc. (NOBH) is expected to report for quarter end 2023-10-31 Walgreens Boots Alliance Inc. (WBA) is expected to report $0.66 for Q1 ...
Disco Corporation ADR (DSCSY) is expected to report for Q2 2024 Sonic Foundry Inc. (SOFO) is expected to report for quarter end 2023-09-30 Sono Group N.V. (SEVCQ) is expected to report for quarter end 2023-09-30 Minim Inc (MINM) is expected to report for Q3 2023 Enel Spa ADR (ENLA...
Enel Spa ADR (ENLAY) is expected to report for Q3 2023 LEG Immobilien SE Registered Shares (LEGIF) is expected to report for Q3 2023 G. Willi-Food International Ltd. (WILC) is expected to report for Q3 2023 Worthington Steel Inc. (WS) is expected to report $0.15 for Q2 2024 Sonic ...